View Single Post
Old 12-14-2008, 06:15 PM   #3
Becky
Senior Member
 
Becky's Avatar
 
Join Date: Sep 2005
Location: Stockton, NJ
Posts: 4,179
First, the study is vague but I will make the following ASSUMPTION that these women had lumpectomy with radiation or masectomy only because tumors less than 1cm (in the past) usually didn't receive chemotherapy.

That said, chemo alone reduces the recurrence rate - I am not sure by how much but when the standard was 4AC followed by 4 taxol every 3 weeks and the study on dense dose (every 2 weeks instead) - that alone reduced recurrence rates by 38%.

So, if we want to be conservative, let's say chemo (regardless of the kind you had), reduces recurrence by 25% (I think its more and we won't take dense dosing into account). Then chemo reduces 23% to 17%. Now add Herceptin which reduces recurrence by half - now you are at 8.6%. That's pretty good and that doesn't take into account that depending on hormone status, exercise can reduce recurrence risk by 20% (hormone positive) to 44% (for hormone negative) so let's use 20% to be conservative and that's less than 7%. A good Meditterean diet and a couple of cups of green tea and you're good to go!

Keep the faith. Keep your face to the sunshine. Smile as much as you can. Be nice to everyone you meet.
__________________
Kind regards

Becky

Found lump via BSE
Diagnosed 8/04 at age 45
1.9cm tumor, ER+PR-, Her2 3+(rt side)
2 micromets to sentinel node
Stage 2A
left 3mm DCIS - low grade ER+PR+Her2 neg
lumpectomies 9/7/04
4DD AC followed by 4 DD taxol
Used Leukine instead of Neulasta
35 rads on right side only
4/05 started Tamoxifen
Started Herceptin 4 months after last Taxol due to
trial results and 2005 ASCO meeting & recommendations
Oophorectomy 8/05
Started Arimidex 9/05
Finished Herceptin (16 months) 9/06
Arimidex Only
Prolia every 6 months for osteopenia

NED 18 years!

Said Christopher Robin to Pooh: "You must remember this: You're braver than you believe and stronger than you seem and smarter than you think"
Becky is offline   Reply With Quote